Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Bagnato

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Journal of Cardiovascular Pharmacology|April 20, 2005
Endothelin-B receptor blockade inhibits molecular effectors of melanoma cell progressionLaura Rosanò, Francesca Spinella, Giulia Genovesi, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Endothelin-1 stimulates cyclooxygenase-2 expression in ovarian cancer cells through multiple signaling pathways: evidence for involvement of transactivation of the epidermal growth factor receptorFrancesca Spinella, Laura Rosanò, Giacomo Elia, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferationLaura Rosanò, Valeriana Di Castro, Francesca Spinella, et al.
Canadian Journal of Physiology and Pharmacology|July 15, 2010
Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancerLaura Rosanò, Roberta Cianfrocca, Francesca Spinella, et al.
Cancer Research|February 20, 2004
Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progressionAnna Bagnato, Laura Rosanò, Francesca Spinella, et al.
Communications Biology|November 14, 2020
Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancerRosanna Sestito, Roberta Cianfrocca, Piera Tocci, et al.
Canadian Journal of Physiology and Pharmacology|August 21, 2010
Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinaseRoberta Cianfrocca, Laura Rosanò, Francesca Spinella, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Endothelin-1 promotes proteolytic activity of ovarian carcinomaLaura Rosanò, Debora Salani, Valeriana Di Castro, et al.
Cell Death & Disease|January 16, 2026
Nuclear gasdermin E drives endothelin-1-induced metastatic progression independently of the pyroptosisCelia Roman, Valentina Caprara, Piera Tocci, et al.
The Journal of Biological Chemistry|August 9, 2003
Endothelin-1 decreases gap junctional intercellular communication by inducing phosphorylation of connexin 43 in human ovarian carcinoma cellsFrancesca Spinella, Laura Rosanò, Valeriana Di Castro, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Journal of Cardiovascular Pharmacology|April 20, 2005
Endothelin-B receptor blockade inhibits molecular effectors of melanoma cell progressionLaura Rosanò, Francesca Spinella, Giulia Genovesi, et al.
Journal of Cardiovascular Pharmacology|April 20, 2005
Endothelin-1 stimulates cyclooxygenase-2 expression in ovarian cancer cells through multiple signaling pathways: evidence for involvement of transactivation of the epidermal growth factor receptorFrancesca Spinella, Laura Rosanò, Giacomo Elia, et al.
Experimental Biology and Medicine (Maywood, N.J.)|June 3, 2006
ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferationLaura Rosanò, Valeriana Di Castro, Francesca Spinella, et al.
Canadian Journal of Physiology and Pharmacology|July 15, 2010
Combination therapy of zibotentan with cisplatinum and paclitaxel is an effective regimen for epithelial ovarian cancerLaura Rosanò, Roberta Cianfrocca, Francesca Spinella, et al.
Cancer Research|February 20, 2004
Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progressionAnna Bagnato, Laura Rosanò, Francesca Spinella, et al.
Communications Biology|November 14, 2020
Targeting endothelin 1 receptor-miR-200b/c-ZEB1 circuitry blunts metastatic progression in ovarian cancerRosanna Sestito, Roberta Cianfrocca, Piera Tocci, et al.
Canadian Journal of Physiology and Pharmacology|August 21, 2010
Beta-arrestin-1 mediates the endothelin-1-induced activation of Akt and integrin-linked kinaseRoberta Cianfrocca, Laura Rosanò, Francesca Spinella, et al.
Clinical Science (London, England : 1979)|August 24, 2002
Endothelin-1 promotes proteolytic activity of ovarian carcinomaLaura Rosanò, Debora Salani, Valeriana Di Castro, et al.
Cell Death & Disease|January 16, 2026
Nuclear gasdermin E drives endothelin-1-induced metastatic progression independently of the pyroptosisCelia Roman, Valentina Caprara, Piera Tocci, et al.
The Journal of Biological Chemistry|August 9, 2003
Endothelin-1 decreases gap junctional intercellular communication by inducing phosphorylation of connexin 43 in human ovarian carcinoma cellsFrancesca Spinella, Laura Rosanò, Valeriana Di Castro, et al.
Pageof 9